CDC2024EN
CDC PrEP Clinical Practice Guideline
Zusammenfassung
CDC CLINICAL GUIDELINE
TITLE: CDC PrEP Clinical Practice Guideline
SOURCE: Centers for Disease Control and Prevention (CDC)
PUBLICATION YEAR: 2024
URL: https://www.cdc.gov/hivnexus/hcp/prep/index.html
LICENSE: Public Domain (US Federal Government)
SPECIALTIES: infectious_disease, primary_care
GUIDELINE CONTENT:
•
•
•
•
•
•
•
Clinical Guidance for PrEP | HIV Nexus | CDC
•
Skip directly to site content
Skip directly to search
An official website of the United States government
Kerninformationen
Whether or not a patient asks for PrEP, it is important to take a sexual and substance use history. This information is essential to understanding each patient's chances of getting HIV, if PrEP might be right for them, and what other risk-reduction services they might need. Use the following flowcha...
Since PrEP is indicated for people with risk factors for HIV, acute HIV infection should be suspected in patients who were recently exposed. Ask all PrEP candidates with a negative or indeterminate HIV test result about whether they have experienced any signs or symptoms of viral infection in the pa...
However, in people with active HBV, stopping these medicines can result in a rebound of HBV replication leading to liver damage. HBV infection is not a contraindication to PrEP, but all people considered for oral PrEP with F/TDF or F/TAF must be screened for HBV. Patients with active HBV infection s...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
StatPearls2026
StatPearls: Preexposure Prophylaxis for HIV Prevention
StatPearls2026
StatPearls: HIV Prevention
WHO2012
Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV
WHO2022
Guidelines on long-acting injectable cabotegravir for HIV prevention
WHO2025